• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血对链激酶和尿激酶激活纤溶酶原的影响。

Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.

作者信息

Takada A, Urano T, Takada Y

出版信息

Thromb Haemost. 1979 Oct 31;42(3):901-8.

PMID:505405
Abstract

Human plasma was mixed with Ca++ or thrombin, and urokinase (UK) or streptokinase (SK) and a chromogenic substrate (S-2251: H-D-Val-Leu-Lys-pNA) specific to plasmin. The hydrolysis of S-2251 was higher when clot was formed by the addition of Ca++ or thrombin than in the absence of clot. The hydrolysis of S-2251 by euglobulin in the presence of UK was also higher when clot was formed, thus, inhibitors may not be related to the better activation of plasminogen, in the presence of fibrin clot. It may be suggested that plasminogen was better activated by activators (UK and SK) in the clot than in its absence.

摘要

将人血浆与钙离子或凝血酶、尿激酶(UK)或链激酶(SK)以及纤溶酶特异性的发色底物(S - 2251:H - D - 缬氨酸 - 亮氨酸 - 赖氨酸 - 对硝基苯胺)混合。通过添加钙离子或凝血酶形成凝块时,S - 2251的水解程度高于未形成凝块时。在有UK存在的情况下,优球蛋白对S - 2251的水解在形成凝块时也更高,因此,在纤维蛋白凝块存在时,抑制剂可能与纤溶酶原的更好激活无关。可以推测,与不存在凝块时相比,凝块中的激活剂(UK和SK)能更好地激活纤溶酶原。

相似文献

1
Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.凝血对链激酶和尿激酶激活纤溶酶原的影响。
Thromb Haemost. 1979 Oct 31;42(3):901-8.
2
Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot.血浆和凝块中纤溶酶与氨甲环酸及α2纤溶酶抑制剂的相互作用。
Thromb Haemost. 1980 Feb 29;43(1):20-3.
3
The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.尿激酶和链激酶对两种纤溶酶原同工酶(I和II)的激活作用。
Thromb Res. 1983 Jun 15;30(6):633-42. doi: 10.1016/0049-3848(83)90272-4.
4
Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
Thromb Diath Haemorrh. 1975 Sep 30;34(1):351.
5
In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.使用血栓弹力图法对纤溶酶原激活剂的纤溶活性进行体外比较:在犬模型中使用预滴定剂量对B链-链激酶复合物进行体内评估。
Thromb Haemost. 1986 Aug 20;56(1):71-9.
6
Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
Thromb Res. 1982 Feb 1;25(3):229-35. doi: 10.1016/0049-3848(82)90242-0.
7
Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.关于链激酶在人血浆中激活剂形成的研究。III. 根据尿激酶当量对未稀释血浆中激活剂动力学的研究。
Thromb Haemost. 1976 Dec 31;36(3):566-81.
8
[Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].[乙醇和乙醛对尿激酶及链激酶诱导的纤溶酶活性和纤溶酶原激活的抑制作用]
Rocz Akad Med Bialymst (1989). 1988;33-34:53-66.
9
Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.回缩对使用纤维蛋白特异性和非纤维蛋白特异性纤溶酶原激活剂溶解人血凝块的影响。
Thromb Haemost. 1989 Dec 29;62(4):1083-7.
10
On the reliability of plasminogen measurement employing the proactivator-activator converting method.关于采用前活化剂-活化剂转化法进行纤溶酶原测定的可靠性
Thromb Haemost. 1976 Dec 31;36(3):551-65.